SOPHiA GENETICS Launches AI Digital Twins for Oncology
SOPHiA GENETICS (Nasdaq: SOPH), a pacesetter in AI-driven precision medication, at the moment introduced the launch of SOPHiA DDM Digital Twins, a breakthrough analysis expertise that creates dynamic, digital representations of particular person sufferers to simulate potential outcomes and assist oncologists make higher remedy choices. SOPHiA DDM Digital Twins makes use of every affected…
